Caute B, Monsarrat B, Gouardères C, Verdie J C, Lazorthes Y, Cros J, Bastide R
Laboratoire de Pharmacie Galénique, Faculté des Sciences Pharmaceutiques, Université Paul Sabotier, 31400 ToulouseFrance Laboratoire de Pharmacologie et de Toxicologie Fondamentales, CNRS, 31077 Toulouse Cedex France Laboratoire de Neurochirurgie et Neurobiologie Appliquée, Clinique Universitaire de Neurochirurgie, CHU Toulouse-Rangueil, Université Paul Sabatier, 31400 ToulouseFrance.
Pain. 1988 Feb;32(2):141-146. doi: 10.1016/0304-3959(88)90062-0.
The objectives of this study were to compare the pharmacokinetic properties and the duration of analgesia following intrathecal administration (L5-S1) of 2 mg morphine in 2 forms: (1) an isobaric (NaCl 0.9%) and (2) a hyperbaric solution (7% dextrose). The study was carried out on 5 cancer patients with severe, intractable pain in the lower half of the body. Samples of CSF were collected at the level of the 10th thoracic vertebra at regular intervals for 15 h after administration. Morphine concentrations were determined by HPLC. The pharmacokinetic properties of the solutions (I and II) were quite different. Peak levels (I) were reached in 5-15 min (30 and 60 micrograms/ml); they then fell rapidly during the 1st hour (7 and 11 micrograms/ml) with an elimination half-life of 10 and 15 min, followed by a change in slope (elimination half-life of 108 and 140 min). Peak levels (II) were reached in 4-5 h (0.8-3.3 micrograms/ml); they then fell progressively according to a single exponential function (elimination half-life: 144-246 min). The duration of analgesia for a dose of 2 mg was 30 h for solution 2 and 24 h for solution 1. The hyperbaric solution, which produced the same degree of analgesia as the isobaric solution, limited the cephalad diffusion of morphine and reduced or abolished the central depressant effects of the drug.
本研究的目的是比较鞘内注射(L5-S1)2mg两种剂型吗啡后的药代动力学特性和镇痛持续时间:(1)等比重溶液(0.9%氯化钠溶液)和(2)高比重溶液(7%葡萄糖溶液)。该研究在5例患有严重、顽固性下半身疼痛的癌症患者身上进行。给药后15小时内,每隔一定时间在第10胸椎水平采集脑脊液样本。采用高效液相色谱法测定吗啡浓度。两种溶液(I和II)的药代动力学特性差异很大。溶液I在5-15分钟内达到峰值水平(30和60微克/毫升);然后在第1小时内迅速下降(7和11微克/毫升),消除半衰期为10和15分钟,随后斜率发生变化(消除半衰期为108和140分钟)。溶液II在4-5小时内达到峰值水平(0.8-3.3微克/毫升);然后根据单指数函数逐渐下降(消除半衰期:144-246分钟)。2mg剂量的镇痛持续时间,溶液2为30小时,溶液1为24小时。高比重溶液与等比重溶液产生相同程度的镇痛效果,限制了吗啡向头端的扩散,并减少或消除了药物的中枢抑制作用。